CLIMB BIO, INC. Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
CLIMB BIO, INC. (CLYM) reported Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount of -$12.57 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate · last filed 2026-03-05
- CLIMB BIO, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2025 was -$12.57M.
- CLIMB BIO, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2024 was -$15.52M.
- CLIMB BIO, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2023 was -$7.38M.
- CLIMB BIO, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2022 was -$9.50M.
| Period end | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month |
|---|---|
| 2025-12-31 | -$12.57M 10-K · filed 2026-03-05 |
| 2024-12-31 | -$15.52M 10-K · filed 2026-03-05 |
| 2023-12-31 | -$7.38M 10-K · filed 2025-03-25 |
| 2022-12-31 | -$9.50M 10-K · filed 2024-03-28 |
| 2021-12-31 | -$9.96M 10-K · filed 2023-03-06 |
| 2020-12-31 | -$4.34M 10-K · filed 2022-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |